ERJ Podcast May 2025: Efficacy and safety of the activin signalling inhibitor sotatercept
ERS Publications Podcasts29 Mai 2025

ERJ Podcast May 2025: Efficacy and safety of the activin signalling inhibitor sotatercept

As part of the May issue, the European Respiratory Journal presents the latest in its series of podcasts. Chief Editor James Chalmers interviews Associate Editor Marius Hoeper about the efficacy and safety of the activin signalling inhibitor sotatercept in a pooled analysis of PULSAR and STELLAR studies.

Populært innen Vitenskap

fastlegen
tingenes-tilstand
rekommandert
jss
rss-rekommandert
sinnsyn
tomprat-med-gunnar-tjomlid
villmarksliv
fjellsportpodden
forskningno
rss-paradigmepodden
rss-overskuddsliv
pod-britannia
tidlose-historier
dekodet-2
rss-skogkurs-podden
rss-nysgjerrige-norge
vett-og-vitenskap-med-gaute-einevoll
kvinnehelsepodden
hva-er-greia-med